Microport Scientific Corp operates within the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Microport Scientific Corp with three other
companies in this sector in China:
Thalys Medical Technology Inc
sales of 920.52 million Chinese Renmimbi [US$132.43 million]
of which 81%
was Intensive selling business),
(1.03 billion Chinese Renmimbi [US$148.61 million]
of which 98%
was Medical Devices), and
SonoScape Medical Corp
(989.07 million Chinese Renmimbi [US$142.29 million]
of which 84%
was Color Doppler Ultrasound).
During the year ended December of 2017, sales at
Microport Scientific Corp were 2.99 billion Chinese Renmimbi (US$430.37 million).
increase of 15.3%
versus 2016, when the company's sales were 2.59 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Microport Scientific Corp
(and since 2012, sales have increased a total of 221%).
Sales of Neurovascular saw an increase
that was more than double the company's growth rate: sales were up
54.8% in 2017, from
58.78 million Chinese Renmimbi to 91.01 million Chinese Renmimbi.
Microport Scientific Corp also saw significant increases in sales in
Cardiovascular (up 21.6% to 1.12 billion Chinese Renmimbi)
Endovascular (up 32.8% to 166.98 million Chinese Renmimbi)
Electrophysiology Devices Business (up 36.9% to 63.42 million Chinese Renmimbi)
Not all segments of Microport Scientific Corp experienced an increase in sales in 2017:
sales of Diabetes Devices fell 54.8% to 4.82 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).